"The company does not have the cash to see it through to a cashflow positive state so funding has to come from somewhere. That is a major source of uncertainty."
Agreed, but there isn't any reason to conclude that the cash has to come from a new stock issue. I think it is far more likely to be earnings form operations that provides the needed cash flow: profits and royalties on ongoing commercial activity plus royalties and payments from other deals in the making but not yet announced.
Let's put it this way: If this company can get to this stage of development and fail to nail down deals with cash up front over the next 6 to 12 months, then something is very, VERY wrong with the business plan.
- Forums
- ASX - By Stock
- great news
"The company does not have the cash to see it through to a...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $2.565K | 874.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 40547400 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 39021116 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 40547400 | 0.002 |
30 | 74217741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39021116 | 27 |
0.004 | 16680899 | 15 |
0.005 | 10825266 | 10 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 15.59pm 12/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online